These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1682023)

  • 41. Natural history of HIV-1 cell-free viremia.
    Henrard DR; Phillips JF; Muenz LR; Blattner WA; Wiesner D; Eyster ME; Goedert JJ
    JAMA; 1995 Aug; 274(7):554-8. PubMed ID: 7629984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pathogenesis of HIV infection.
    Ortona L; Antinori A
    Rays; 1994; 19(1):15-28. PubMed ID: 7913242
    [No Abstract]   [Full Text] [Related]  

  • 43. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GM-CSF production by CD4+ T-lymphocytes is selectively impaired during the course of HIV-1 infection. A possible indication of a preferential lesion of a specific subset of peripheral blood CD4+ T-lymphocytes.
    Re MC; Zauli G; Furlini G; Giovannini M; Ranieri S; Ramazzotti E; Vignoli M; La Placa M
    Microbiologica; 1992 Jul; 15(3):265-70. PubMed ID: 1354325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acquired immunodeficiency syndrome.
    Lane HC
    Dermatol Clin; 1990 Oct; 8(4):771-86. PubMed ID: 1979021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical manifestations and the problems of classification of HIV infection].
    Iurin OG; Irova TI; Gabrilovich DI; Suvorova ZK; Kravchenko AV; Potekaev NS; Kharchenko OI; Pokrovskiĭ VV
    Vestn Ross Akad Med Nauk; 1992; (9-10):16-9. PubMed ID: 1283710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of naive T cells may play major role in weakened immune response.
    Prescott LM
    J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):32. PubMed ID: 11362311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Storage as a factor in enumeration of CD4+ lymphocytes.
    Moll B
    J Infect Dis; 1992 Nov; 166(5):1198-9. PubMed ID: 1402038
    [No Abstract]   [Full Text] [Related]  

  • 49. Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.
    Aledort LM; Hilgartner MW; Pike MC; Gjerset GF; Koerper MA; Lian EY; Lusher JM; Mosley JW
    BMJ; 1992 Jan; 304(6821):212-6. PubMed ID: 1346752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Passive immunotherapy in treatment of advanced human immunodeficiency virus infection.
    Karpas A
    J Infect Dis; 1994 Sep; 170(3):742-4. PubMed ID: 8077741
    [No Abstract]   [Full Text] [Related]  

  • 51. Selected micronutrient levels and response to highly active antiretroviral therapy (HAART) among HIV/AIDS patients attending a teaching Hospital in Addis Ababa, Ethiopia.
    Eshetu A; Tsegaye A; Petros B
    Biol Trace Elem Res; 2014 Dec; 162(1-3):106-12. PubMed ID: 25256923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS.
    Choi BS; Park YK; Lee JS
    Clin Exp Immunol; 2002 Jan; 127(1):137-44. PubMed ID: 11882044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rheumatoid arthritis and AIDS.
    Jaffe IA
    Mod Pathol; 1994 Feb; 7(2):153-4. PubMed ID: 7911995
    [No Abstract]   [Full Text] [Related]  

  • 54. Correlation of spontaneous suppressor cell activity with progression of human immunodeficiency virus infection.
    Mullin G; Mayer L
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):387-92. PubMed ID: 1676898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and specificity of lymphocytotoxic antibodies in different stages of HIV infection.
    Szabó B; Tóth FD; Kiss J; Füst G; Ujhelyi E; Bánhegyi D; Horváth A; Hollán SR
    Acta Virol; 1992 Aug; 36(4):392-400. PubMed ID: 1362323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative complement pathway activation by CD4+ T cells of HIV infected individuals: a possible role in AIDS pathogenesis.
    Yefenof E; Magyarlaki T; Fenyo EM; Wahren B; Klein E
    Int Immunol; 1994 Sep; 6(9):1361-6. PubMed ID: 7819144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV infection in the era of cytomics.
    Cossarizza A
    Cytometry A; 2010 Aug; 77(8):721-4. PubMed ID: 20653011
    [No Abstract]   [Full Text] [Related]  

  • 58. Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
    Hazenberg MD; Otto SA; van Benthem BH; Roos MT; Coutinho RA; Lange JM; Hamann D; Prins M; Miedema F
    AIDS; 2003 Sep; 17(13):1881-8. PubMed ID: 12960820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the T-cell receptor in HIV infection.
    Amiel C; Gobert B; Béné MC; May T; Canton P; Faure GC
    Pathol Biol (Paris); 1992 Jun; 40(6):627-31. PubMed ID: 1408381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The risk for development of AIDS in HIV infection].
    Morio S; Soda K
    Nihon Rinsho; 1993 Sep; 51 Suppl():254-8. PubMed ID: 7903708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.